Page last updated: 2024-08-24

triazoles and Epilepsy, Absence

triazoles has been researched along with Epilepsy, Absence in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Ari, C; Brunner, B; D'Agostino, DP; Kovács, Z1
Huang, LJ; Peng, Y; Peng, YC; Wang, S; Wang, XL; Zhang, Y1
Albini, M; Casciato, S; Di Bonaventura, C; Fanella, M; Fattouch, J; Giallonardo, AT; Lapenta, L; Manfredi, M; Morano, A1
Aleksza, M; Dobolyi, Á; Juhász, G; Kékesi, KA; Kovács, Z; Lakatos, RK; Todorov, MI1
Ballerini, P; Biagioni, F; Buccella, S; Caciagli, F; Ciccarelli, R; Citraro, R; D'Alimonte, I; D'Auro, M; De Sarro, G; Di Iorio, P; Giuliani, P; Jiang, S; Nargi, E; Russo, E1
Benedict, A; Maclaine, G; Verdian, L1
Arroyo, S; Glauser, T; Kluger, G; Krauss, G; Perdomo, C; Sachdeo, R1
Ates, N; Coenen, AM; Drinkenburg, WH; van Luijtelaar, EL; Vossen, JM1

Reviews

1 review(s) available for triazoles and Epilepsy, Absence

ArticleYear
Effectiveness of Rufinamide in the Treatment of Idiopathic Generalized Epilepsy With Atypical Evolution: Case Report and Review of the Literature.
    Clinical EEG and neuroscience, 2016, Volume: 47, Issue:2

    Topics: Adult; Anticonvulsants; Disease Progression; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Treatment Outcome; Triazoles

2016

Trials

1 trial(s) available for triazoles and Epilepsy, Absence

ArticleYear
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
    Neurology, 2008, May-20, Volume: 70, Issue:21

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Male; Syndrome; Treatment Outcome; Triazoles

2008

Other Studies

6 other study(ies) available for triazoles and Epilepsy, Absence

ArticleYear
Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.
    Nutrients, 2021, Nov-15, Volume: 13, Issue:11

    Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Weight; Dietary Supplements; Disease Models, Animal; Epilepsy, Absence; Injections, Intraperitoneal; Ketones; Ketosis; Lipopolysaccharides; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptors, Purinergic P1; Triazoles; Xanthines

2021
Hsp90β inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy.
    Journal of Asian natural products research, 2019, Volume: 21, Issue:9

    Topics: Animals; Anticonvulsants; Benzoquinones; Epilepsy, Absence; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; HSP90 Heat-Shock Proteins; Lactams, Macrocyclic; Mice; Pentylenetetrazole; Triazoles

2019
Guanosine may increase absence epileptic activity by means of A2A adenosine receptors in Wistar Albino Glaxo Rijswijk rats.
    Brain research bulletin, 2016, Volume: 124

    Topics: Adenosine A2 Receptor Antagonists; Animals; Anticonvulsants; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Fourier Analysis; Guanosine; Indomethacin; Lipopolysaccharides; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Theophylline; Time Factors; Triazoles

2016
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.
    The European journal of neuroscience, 2009, Volume: 30, Issue:6

    Topics: Adenosine; Age Factors; Analysis of Variance; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Electroencephalography; Epilepsy, Absence; Glutamic Acid; Immunohistochemistry; Male; MAP Kinase Signaling System; Microinjections; Phenethylamines; Pyrimidines; Rats; Receptor, Adenosine A2A; Somatosensory Cortex; Thalamus; Triazoles

2009
The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.
    PharmacoEconomics, 2010, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Computer Simulation; Cost-Benefit Analysis; Epilepsy, Absence; Fructose; Health Care Costs; Humans; Infant; Intellectual Disability; Lamotrigine; Models, Economic; Randomized Controlled Trials as Topic; Syndrome; Time Factors; Topiramate; Treatment Outcome; Triazines; Triazoles; United Kingdom

2010
Effects of loreclezole on epileptic activity and on EEG and behaviour in rats with absence seizures.
    Epilepsy research, 1992, Volume: 13, Issue:1

    Topics: Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Exploratory Behavior; Female; Male; Rats; Rats, Inbred Strains; Triazoles

1992